J
Juliette M. K. M. Delhove
Researcher at University of Adelaide
Publications - 27
Citations - 472
Juliette M. K. M. Delhove is an academic researcher from University of Adelaide. The author has contributed to research in topics: Luciferase & Bioluminescence imaging. The author has an hindex of 9, co-authored 25 publications receiving 351 citations. Previous affiliations of Juliette M. K. M. Delhove include UCL Institute of Child Health & University of the Witwatersrand.
Papers
More filters
Journal ArticleDOI
NRF2 Orchestrates the Metabolic Shift during Induced Pluripotent Stem Cell Reprogramming
Kate E. Hawkins,Shona Joy,Shona Joy,Juliette M. K. M. Delhove,Juliette M. K. M. Delhove,Juliette M. K. M. Delhove,Vassilios N. Kotiadis,Emilio Fernández,Lorna M. FitzPatrick,Lorna M. FitzPatrick,James R. Whiteford,Peter J. King,Juan P. Bolaños,Michael R. Duchen,Simon N. Waddington,Simon N. Waddington,Tristan R. McKay,Tristan R. McKay +17 more
TL;DR: A lentiviral reporter system is developed to assay longitudinal changes in cell signaling and transcription factor activity in living cells throughout iPSC reprogramming of human dermal fibroblasts and shows that an early burst in oxidative phosphorylation and elevated reactive oxygen species generation mediates increased NRF2 activity, which initiates the HIFα-mediated glycolytic shift and may modulate glucose redistribution to the pentose phosphate pathway.
Journal ArticleDOI
MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro
Giampaolo Trivellin,Henriett Butz,Juliette M. K. M. Delhove,Susana Igreja,Harvinder Chahal,Vladimir Zivkovic,Tristan R. McKay,Attila Patócs,Ashley B. Grossman,Márta Korbonits +9 more
TL;DR: In this article, microRNA expression profiles have been associated with sporadic pituitary adenomas, suggesting that miRNAs can contribute to tumor formation; microRNAs are small noncoding RN...
Journal ArticleDOI
Public Acceptability of Gene Therapy and Gene Editing for Human Use: A Systematic Review
Juliette M. K. M. Delhove,Juliette M. K. M. Delhove,Ivana Osenk,Ivanka Prichard,Martin Donnelley,Martin Donnelley +5 more
TL;DR: In this article, the authors discuss the need for patient and public support for gene therapy and gene editing technologies in order to understand their possible benefits or side effects and their potential side effects.
Journal ArticleDOI
In vivo bioimaging with tissue-specific transcription factor activated luciferase reporters
Suzanne M. K. Buckley,Juliette M. K. M. Delhove,Juliette M. K. M. Delhove,Dany P. Perocheau,Rajvinder Karda,Rajvinder Karda,AA Rahim,Steven J. Howe,NJ Ward,Mark A. Birrell,Maria G. Belvisi,Patrick Arbuthnot,Mark R. Johnson,Simon N. Waddington,Simon N. Waddington,Tristan R. McKay +15 more
TL;DR: This work presents a novel approach of tissue-targeted delivery of transcription factor activated luciferase reporter lentiviruses to neonatal rodents as an alternative to the existing technology of generating germline transgenic light producing rodents and shows the malleability of this technology by quantifying NFκB-mediatedLuciferase expression in outbred rats.
Journal ArticleDOI
BMI-1 extends proliferative potential of human bronchial epithelial cells while retaining their mucociliary differentiation capacity.
Mustafa M. Munye,Amelia Shoemark,Robert A. Hirst,Juliette M. K. M. Delhove,Tyson V. Sharp,Tristan R. McKay,Chistopher O'Callaghan,Deborah L. Baines,Steven J. Howe,Stephen L. Hart +9 more
TL;DR: BMI-1 delayed senescence in bronchial epithelial cells, increasing their proliferative potential but maintaining mucociliary differentiation at ALI, has shown these cells are amenable to genetic manipulation and can be used to produce novel disease models for research and dissemination.